Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Palmieri, G.
Right arrow Articles by Castello, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Palmieri, G.
Right arrow Articles by Castello, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 19, Issue 5 (March), 2001: 1437-1443
© 2001 American Society for Clinical Oncology

Detection of Occult Melanoma Cells in Paraffin-Embedded Histologically Negative Sentinel Lymph Nodes Using a Reverse Transcriptase Polymerase Chain Reaction Assay

By Giuseppe Palmieri, Paolo A. Ascierto, Antonio Cossu, Nicola Mozzillo, Maria L. Motti, Sabrina M.R. Satriano, Gerardo Botti, Corrado Caracò, Egidio Celentano, Rocco A. Satriano, Amelia Lissia, Francesco Tanda, Mario Pirastu, Giuseppe Castello, for the Melanoma Cooperative Group

From the Institute of Molecular Genetics, National Research Council of Italy, Alghero (SS); the Institute of Pathology, University of Sassari, Sassari; the National Tumor Institute "Fondazione G. Pascale"; and the Department of Dermatology, Second University of Naples, Naples, Italy

Address reprint requests to Giuseppe Palmieri, MD, Institute of Molecular Genetics, National Research Council of Italy, Alghero (SS), Casella Postale, 07040 Santa Maria La Palma (Sassari), Italy; email: gpalmieri{at}yahoo.com

PURPOSE: Detection of occult metastasis before the development of clinical disease could allow more accurate staging, appropriate follow-up procedures, and adjuvant therapies in patients with malignant melanoma (MM). The sentinel lymph node (SLN) has been proposed as a reliable predictor of metastatic disease in the lymphatic basin draining the primary melanoma. In this study, we screened both paraffin-embedded SLNs and peripheral-blood (PB) samples from MM patients at various stage of disease using a multimarker reverse transcriptase polymerase chain reaction (RT-PCR) assay. The prognostic significance of the presence of PCR-positive markers was also evaluated.

PATIENTS AND METHODS: Total RNA was obtained from paraffin-embedded SLN sections and PB samples of 75 MM patients. RT-PCR was performed using tyrosinase and MelanA/MART1 as melanoma-associated markers. Radiolabeled PCR products were analyzed on denaturing polyacrylamide gels.

RESULTS: Good sensitivity of the RT-PCR assay on archival tissues was demonstrated after comparison of RT-PCR results on frozen and paraffin-embedded SLNs from 16 MM patients. Significant correlation between the disease stage and marker expression in both PB and SLN samples was observed; the highest value was for patients who were positive for both markers in SLN (P = .006). Progression of disease was significantly associated with the total number of PCR-positive markers in both PB (P = .034) and SLN (P = .001) samples.

CONCLUSION: Although sensitivity is lowered by the use of paraffin-embedded specimens, our data indicate that RT-PCR analysis of serial sections from archival SLNs may be helpful in improving detection of occult micrometastases, thus improving staging of patients with melanoma.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
D. L. Morton, R. P. Scheri, and C. M. Balch
Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?
Ann. Surg. Oncol., September 1, 2007; 14(9): 2437 - 2439.
[Full Text] [PDF]


Home page
JCOHome page
S. Mocellin, D. S.B. Hoon, P. Pilati, C. R. Rossi, and D. Nitti
Sentinel Lymph Node Molecular Ultrastaging in Patients With Melanoma: A Systematic Review and Meta-Analysis of Prognosis
J. Clin. Oncol., April 20, 2007; 25(12): 1588 - 1595.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
C. R. Scoggins, M. I. Ross, D. S. Reintgen, R. D. Noyes, J. S. Goydos, P. D. Beitsch, M. M. Urist, S. Ariyan, B. S. Davidson, J. J. Sussman, et al.
Prospective Multi-Institutional Study of Reverse Transcriptase Polymerase Chain Reaction for Molecular Staging of Melanoma
J. Clin. Oncol., June 20, 2006; 24(18): 2849 - 2857.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Raja, J. Ching, L. Xi, S. J. Hughes, R. Chang, W. Wong, W. McMillan, W. E. Gooding, K. S. McCarty Jr, M. Chestney, et al.
Technology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical Testing
Clin. Chem., May 1, 2005; 51(5): 882 - 890.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
H. N. Abrahamsen, B. Sandahl Sorensen, E. Nexo, S. J. Hamilton-Dutoit, J. Larsen, and T. Steiniche
Pathologic Assessment of Melanoma Sentinel Nodes: A Role for Molecular Analysis Using Quantitative Real-Time Reverse Transcription-PCR for MART-1 and Tyrosinase Messenger RNA
Clin. Cancer Res., February 15, 2005; 11(4): 1425 - 1433.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Bibikova, J. M. Yeakley, E. Chudin, J. Chen, E. Wickham, J. Wang-Rodriguez, and J.-B. Fan
Gene Expression Profiles in Formalin-Fixed, Paraffin-Embedded Tissues Obtained with a Novel Assay for Microarray Analysis
Clin. Chem., December 1, 2004; 50(12): 2384 - 2386.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. Wlodzimierz, P. Rutkowski, Z. I. Nowecki, J. Kulik, A. Nasierowska-Guttmejer, and J. A. Siedlecki
Detection of Melanoma Cells in the Lymphatic Drainage after Lymph Node Dissection in Melanoma Patients by Using Two-Marker Reverse Transcriptase-Polymerase Chain Reaction Assay
Ann. Surg. Oncol., November 1, 2004; 11(11): 988 - 997.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Bibikova, D. Talantov, E. Chudin, J. M. Yeakley, J. Chen, D. Doucet, E. Wickham, D. Atkins, D. Barker, M. Chee, et al.
Quantitative Gene Expression Profiling in Formalin-Fixed, Paraffin-Embedded Tissues Using Universal Bead Arrays
Am. J. Pathol., November 1, 2004; 165(5): 1799 - 1807.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. Takeuchi, D. L. Morton, C. Kuo, R. R. Turner, D. Elashoff, R. Elashoff, B. Taback, A. Fujimoto, and D. S.B. Hoon
Prognostic Significance of Molecular Upstaging of Paraffin-Embedded Sentinel Lymph Nodes in Melanoma Patients
J. Clin. Oncol., July 1, 2004; 22(13): 2671 - 2680.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Gonzalez Cao, S. Puig, and B. Mellado
Survivin Expression in Sentinel Lymph Nodes From Melanoma Patients
J. Clin. Oncol., July 1, 2004; 22(13): 2751 - 2752.
[Full Text] [PDF]


Home page
JCOHome page
G. Palmieri, P. A. Ascierto, F. Perrone, S. M.R. Satriano, A. Ottaiano, A. Daponte, M. Napolitano, C. Caraco, N. Mozzillo, M. T. Melucci, et al.
Prognostic Value of Circulating Melanoma Cells Detected by Reverse Transcriptase-Polymerase Chain Reaction
J. Clin. Oncol., March 1, 2003; 21(5): 767 - 773.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Mariani, M. Gipponi, L. Moresco, G. Villa, M. Bartolomei, G. Mazzarol, M. C. Bagnara, A. Romanini, F. Cafiero, G. Paganelli, et al.
Radioguided Sentinel Lymph Node Biopsy in Malignant Cutaneous Melanoma*
J. Nucl. Med., June 1, 2002; 43(6): 811 - 827.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2001 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online